Icotrokinra (JNJ-77242113)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Icotrokinra (JNJ-77242113), covering 2026-06-05 to 2026-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis [Phase 3]